retatrutide triple hormone receptor agonist benefits UK 2026: Phase 3 Results Tirzepatide vs. Retatrutide: Key Differences

This dual impact makes these medications a compelling option for managing PCOS

However, the authors noted prior evidence from studies like Bezin et al

As specialists in womens care and pregnancy, weve observed that women and those who have been pregnant often struggle with stubborn fat, which can significantly impact self-esteem

It is approved by the Food and Drug Administration (FDA) as an injectable diabetes drug that is indicated as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes patients

For weight loss, the injections are approved for people with a BMI of 27 and above, and weight loss surgery is approved for a BMI of 30 and above, though its more common among people with with a BMI over 35

While today's medications may be becoming more affordable, newer therapies are expected to enter the market that may offer greater efficacy , but come with higher costs